Neogenomics, Inc. · NASDAQ:NEO
Kelly Michael Aaron exercised options for 23,077 Neogenomics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Kelly Michael Aaron (Director) exercised options for 23,077 Neogenomics, Inc. shares, leaving 67,086 shares. Filed Jun 3, 2026 (Form 4).
- Options exercised
- 23,077 shares
- Holding after
- 67,086 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 23,077 | 67,086 | Direct |